Acta Med. 2005, 48: 163-164
https://doi.org/10.14712/18059694.2018.46
Mucosal Mast Cells in Irritable Bowel Syndrome and Inflammatory Bowel Disease
References
1. AP, Thompson WG, Heaton KW et al. Toward positive diagnosis of irritable bowel. Br Med J 1978; 32:334–6.
2. WG, Creed F, Drossman DA, et al. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992; 5:75–91.
3. S, Weidenhiller M, Otte P et al. Urinary excretion of N-methyl histamine as a marker of disease activity in inflammatory bowel disease. Am J Gastroenterol 2002; 97(12):3071–7.
<https://doi.org/10.1111/j.1572-0241.2002.07028.x>
4. II, Glubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 2002; 104(2):185–92.
<https://doi.org/10.1078/0065-1281-00641>
5. Y, Kasai H, Takahashi H et al. The role of mast cells in the development of 2,4,6–trinitrobenzene sulfonic acid-induced colitis in rats. Scand J Gastroenterol 2002; 37(5):555–60.
<https://doi.org/10.1080/00365520252903107>
6. J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48(5):630–6.
<https://doi.org/10.1136/gut.48.5.630>
<PubMed>
7. RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn’s disease. Med Clin North Am 1994; 78:1207.
<https://doi.org/10.1016/S0025-7125(16)30096-7>
8. SM, Vallance B, Barbara G, Borgaonkar M. Putative inflammatory and immunological bowel mechanisms in functional bowel disorders. Bailieres Best Pract Res Clin Gastroenterol 1999; 13(3):429–36.
<https://doi.org/10.1053/bega.1999.0037>
9. A, Ishikawa N, Eto T, Nawa Y. Evaluation of the role of mast cells in the progression of acetic acid induced colitis in mice. Scand J Gastroenterol 1996; 31(8):774–7.
<https://doi.org/10.3109/00365529609010351>
